Abstract：Objective To construct a prediction model for preeclampsia (PE) risk in twin-pregnant women, so as to provide the basis for early screening and prevention of PE. Methods A total of 467 twin-pregnant women who underwent prenatal examination and delivered at Huzhou Maternal and Child Health Hospital were selected. Sixty cases with preeclampsia (PE) were included in the case group, and 60 women without PE were included in the control group. General information, blood biochemical indicators and uterine artery resistance index (UtA-RI) were collected. A logistic regression model was used to screen predictive factors and establish a nomogram. The Bootstrap method was performed for the internal validation; the receiver operating characteristic (ROC) curve, calibration curve and decision curve analysis were employed to evaluate the discrimination, calibration and clinical utility of the nomogram, respectively. Results In the case group, there were 47 individuals (78.33%) aged younger than 35 years, 21 individuals (35.00%) with pre-pregnancy body mass index (BMI) of 25 kg/m2 and above, and 33 individuals (55.00%) with in vitro fertilization. In the control group, there were 57 individuals (95.00%) aged younger than 35 years, 8 individuals (13.33%) with pre-pregnancy BMI of 25 kg/m2 and above, and 39 individuals (65.00%) with natural pregnancy. Multivariable logistic regression analysis identified age, pre-pregnancy BMI, method of conception, placental growth factor (PLGF) and UtA-RI as risk prediction factors for PE in twin-pregnant women. The established nomogram had an area under the ROC curve of 0.827 (95%CI: 0.755-0.899), a sensitivity of 0.767, a specificity of 0.733, a good discrimination and calibration, and a relatively high clinical net benefit. Conclusion The nomogram established by age, pre-pregnancy BMI, method of conception, PLGF and UtA-RI has a good predictive value for the risk of PE in twin-pregnant women.
[1] CHANTANAHOM N,PHUPONG V.Clinical risk factors for preeclampsia in twin pregnancies[J].PLoS One,2021,16(4):1-8. [2] POON L C,SHENNAN A,HYETT J A,et al.The International Federation of Gynecology and Obstetrics(FIGO)initiative on pre-eclampsia:a pragmatic guide for first-trimester screening and prevention[J].Int J Gynaecol Obstet,2019,145(Suppl.1):1-33. [3] 张芝银,李秀央,郑国英,等.不良妊娠结局的影响因素分析[J].预防医学,2020,32(1):94-97. [4] ROBERGE S,NICOLAIDES K,DEMERS S,et al.The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction:systematic review and meta-analysis[J].Am J Obstet Gynecol,2017,216(2):110-120. [5] National Collaborating Centre for Women's and Children's Health(UK).Multiple pregnancy:the management of twin and triplet pregnancies in the antenatal period[M].London:RCOG Press,2011. [6] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020,55(4):227-238. [7] U.S.Preventive Services Task Force.Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia:U.S.Preventive Services Task Force recommendation statement[J].Ann Intern Med,2014,161(11):819-826. [8] DE KAT A C,HIRST J,WOODWARD M,et al.Prediction models for preeclampsia:a systematic review[J].Pregnancy Hypertens,2019,16:48-66. [9] 谢金亮,王筱金,王炳顺.双胎妊娠子痫前期的预测进展[J].中华围产医学杂志,2023,26(7):601-606. [10] POON L C,KAMETAS N A,CHELEMEN T,et al.Maternal risk factors for hypertensive disorders in pregnancy:a multivariate approach[J].J Hum Hypertens,2010,24(2):104-110. [11] FRANCISCO C,WRIGHT D,BENKŐ Z,et al.Competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history[J].Ultrasound Obstet Gynecol,2017,50(4):501-506. [12] HU J,GAO J,LIU J,et al.Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China[J].Ultrasound Obstet Gynecol,2021,58(4):529-539. [13] 李丽洁,王梁萍,郑艳鹛.抑制素A、激活素A与子宫动脉搏动指数联合预测子痫前期的效果分析[J].预防医学,2017,29(3):251-254,259. [14] SVIRSKY R,LEVINSOHN-TAVOR O,FELDMAN N,et al.First-and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy[J].Ultrasound Obstet Gynecol,2016,47(5):560-564. [15] MAYMON R,TRAHTENHERTS A,SVIRSKY R,et al.Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies[J].Hypertens Pregnancy,2017,36(1):108-115. [16] FOX N S,ROMAN A S,SALTZMAN D H,et al.Risk factors for preeclampsia in twin pregnancies[J].Am J Perinatol,2014,31(2):163-166. [17] TAGUCHI T,ISHII K,HAYASHI S,et al.Clinical features and prenatal risk factors for hypertensive disorders in twin pregnancies[J].J Obstet Gynaecol Res,2014,40(6):1584-1591. [18] HAN Q,ZHENG S S,CHEN R X,et al.A new model for the predicting the risk of preeclampsia in twin pregnancy[J].Front Physiol,2022,13:1-9. [19] CHEN J P,ZHAO D P,LIU Y,et al.Screening for preeclampsia in low-risk twin pregnancies at early gestation[J].Acta Obstet Gynecol Scand,2020,99(10):1346-1353. [20] LU Y,DING Z Y,LI W W,et al.Prediction of twin pregnancy preeclampsia based on clinical risk factors,early pregnancy serum markers,and uterine artery pulsatility index[J].Pak J Med Sci,2021,37(7):1727-1733. [21] 陆艳,丁忠英,李雯雯,等.子宫动脉阻力指数联合临床风险因素预测双胎孕妇子痫前期的应用价值[J].浙江医学,2021,43(20):2185-2189.
